FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289525816> ?p ?o ?g. }

• W4289525816 endingPage "122073" @default.
• W4289525816 startingPage "122073" @default.
• W4289525816 abstract "Biofiber is a new generation of highly absorbent, and textured bandage with patented fiber technology. Biofiber has a sophisticated texture that provides an optimum balance of moisture, flexibility, and conformability, and it has been developed with specific properties to treat complex injuries like burns. The dressing has been designed to be completely adaptable to human anatomy, and it can be fitted to any part of the body, adapting to all curves and jointures, as well as fitting the facial features. Prototypes of PLA-PCL-based textured bandages were developed by electrospinning, characterized, and evaluated for complex wound care. The texture is both esthetic and functional; fibers were uniformly sized (2.2 ± 0.8 and 4.5 ± 0.3 µm) and well interconnected. The texture facilitates vertical absorption of exudate up to 2.5 g/g of bandage, and the high contact angle values (120 - 100°) create an optimum balance of moisture for the healing process. The textured prototypes turned out to be extremely stable; no sign of bandage debris was found by the standard test, BS EN 13726-1.7. In addition, the round texture (3R) showed improvements in tensile strength (0.27 ± 0.019 MPa), ultimate tensile strength (0.83 ± 0.05 MPa) with higher breaking point (0.91 ± 0.05 MPa) compared to control (Mepilex Lite®). The amount of albumin (BSA) and Fibrinogen (Fb) adhered on textured fiber prototypes was calculated by BCA Assay, all prototypes demonstrated strong BSA (ranging from 81.66 ± 8.93 to 182.73 ± 2.07 μg protein/mg dressing) and enhanced Fb shielding (ranging from 108.25 ± 7.3 to 238.12 ± 17.76 μg protein/mg dressing). Their MVTR values ranged from 2313.27 ± 58.86 to 2603.33 ± 50.41 g/m2· day and vertical wicking heights were between 24.6 ± 2.5 and 29.3 ± 4.1 mm; biological tests demonstrated good compatibility of prototypes (cell vitality > 70 %), percentage of cells attachment was in-between 114 and 225 %. The extent of attachment depends on texture, differing topographical patterns presented higher attachment compared with both CTR + and 1P prototype (no texture). Cells were growth on textured fiber prototypes, and the extent of proliferation depend on incubation time." @default.
• W4289525816 created "2022-08-03" @default.
• W4289525816 creator A5002453648 @default.
• W4289525816 creator A5035127057 @default.
• W4289525816 creator A5036491149 @default.
• W4289525816 creator A5048453889 @default.
• W4289525816 creator A5050504480 @default.
• W4289525816 creator A5064069613 @default.
• W4289525816 creator A5071533160 @default.
• W4289525816 creator A5086436089 @default.
• W4289525816 date "2022-09-01" @default.
• W4289525816 modified "2023-10-15" @default.
• W4289525816 title "BioFiber: An advanced fibrous textured dressing to manage exudate in severe wounds" @default.
• W4289525816 cites W1762804241 @default.
• W4289525816 cites W1899967153 @default.
• W4289525816 cites W1969614598 @default.
• W4289525816 cites W1979978698 @default.
• W4289525816 cites W1995056718 @default.
• W4289525816 cites W1996562151 @default.
• W4289525816 cites W2005531395 @default.
• W4289525816 cites W2005694693 @default.
• W4289525816 cites W2090004724 @default.
• W4289525816 cites W2141198688 @default.
• W4289525816 cites W2176823143 @default.
• W4289525816 cites W2326989767 @default.
• W4289525816 cites W2340395657 @default.
• W4289525816 cites W2526166493 @default.
• W4289525816 cites W2591251135 @default.
• W4289525816 cites W2604165606 @default.
• W4289525816 cites W2612143811 @default.
• W4289525816 cites W2739821164 @default.
• W4289525816 cites W2748956455 @default.
• W4289525816 cites W2794605847 @default.
• W4289525816 cites W2802080797 @default.
• W4289525816 cites W2890303837 @default.
• W4289525816 cites W2897143006 @default.
• W4289525816 cites W2934701822 @default.
• W4289525816 cites W2989496028 @default.
• W4289525816 cites W3033027026 @default.
• W4289525816 cites W3092529425 @default.
• W4289525816 cites W3120906449 @default.
• W4289525816 cites W3128157658 @default.
• W4289525816 cites W3132952874 @default.
• W4289525816 cites W3213944910 @default.
• W4289525816 cites W4210970803 @default.
• W4289525816 cites W606472966 @default.
• W4289525816 cites W2964743264 @default.
• W4289525816 doi "https://doi.org/10.1016/j.ijpharm.2022.122073" @default.
• W4289525816 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35931393" @default.
• W4289525816 hasPublicationYear "2022" @default.
• W4289525816 type Work @default.
• W4289525816 citedByCount "3" @default.
• W4289525816 countsByYear W42895258162022 @default.
• W4289525816 countsByYear W42895258162023 @default.
• W4289525816 crossrefType "journal-article" @default.
• W4289525816 hasAuthorship W4289525816A5002453648 @default.
• W4289525816 hasAuthorship W4289525816A5035127057 @default.
• W4289525816 hasAuthorship W4289525816A5036491149 @default.
• W4289525816 hasAuthorship W4289525816A5048453889 @default.
• W4289525816 hasAuthorship W4289525816A5050504480 @default.
• W4289525816 hasAuthorship W4289525816A5064069613 @default.
• W4289525816 hasAuthorship W4289525816A5071533160 @default.
• W4289525816 hasAuthorship W4289525816A5086436089 @default.
• W4289525816 hasConcept C112950240 @default.
• W4289525816 hasConcept C136229726 @default.
• W4289525816 hasConcept C141071460 @default.
• W4289525816 hasConcept C142724271 @default.
• W4289525816 hasConcept C159985019 @default.
• W4289525816 hasConcept C168314062 @default.
• W4289525816 hasConcept C192562407 @default.
• W4289525816 hasConcept C2778573061 @default.
• W4289525816 hasConcept C2779018052 @default.
• W4289525816 hasConcept C519885992 @default.
• W4289525816 hasConcept C71924100 @default.
• W4289525816 hasConceptScore W4289525816C112950240 @default.
• W4289525816 hasConceptScore W4289525816C136229726 @default.
• W4289525816 hasConceptScore W4289525816C141071460 @default.
• W4289525816 hasConceptScore W4289525816C142724271 @default.
• W4289525816 hasConceptScore W4289525816C159985019 @default.
• W4289525816 hasConceptScore W4289525816C168314062 @default.
• W4289525816 hasConceptScore W4289525816C192562407 @default.
• W4289525816 hasConceptScore W4289525816C2778573061 @default.
• W4289525816 hasConceptScore W4289525816C2779018052 @default.
• W4289525816 hasConceptScore W4289525816C519885992 @default.
• W4289525816 hasConceptScore W4289525816C71924100 @default.
• W4289525816 hasFunder F4320322874 @default.
• W4289525816 hasLocation W42895258161 @default.
• W4289525816 hasLocation W42895258162 @default.
• W4289525816 hasOpenAccess W4289525816 @default.
• W4289525816 hasPrimaryLocation W42895258161 @default.
• W4289525816 hasRelatedWork W2002678911 @default.
• W4289525816 hasRelatedWork W2029024880 @default.
• W4289525816 hasRelatedWork W2049206847 @default.
• W4289525816 hasRelatedWork W2152118252 @default.
• W4289525816 hasRelatedWork W2377373347 @default.
• W4289525816 hasRelatedWork W2618006489 @default.
• W4289525816 hasRelatedWork W3103970596 @default.
• W4289525816 hasRelatedWork W3162093305 @default.

• next